Prazital Forte (Praziquintal , Fenbendazole and Pyrantel Parmate

NSP (non -structural protein) free FMD vaccine inactivated; composition: Each dose contains: trivalent NSP free FMD inactivated antigens of O, A and ais-1 strains adsorbed on to aluminium hyddroxide gel, mineral oil, saponion added as adjuvant, thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer ...

Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms

Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms

Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms

Each dose contains: monovalent FMD inactivated antigens of O strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

Rabies veterinary antigen strain-CVS thiomersal ≤ 0.01% w/v added as preservative and cell growth medium q.s

Each 1mL contains: inactivayted rabies viral antigen of potency ≥1.0IU [rabies virus strain CVS propagated on BHK cells ] adsorbed on to aluminium hydroxide gel, thiomersal B.P as preservative ≤0.02% w/v, phosphate buffer diluent q.s to 1mL

blue tongue vaccine, inactivated Each dose (2mL) contains: BTV-01 strain (mean antibody titre ≥ 1:20) , BTV-02 strain (mean antibody titre ≥ 1:20), BTV-10 strain (mean antibody titre ≥ 1:20), BTV-16 strain (mean antibody titre ≥ 1:20), BTV-23 strain (mean antibody titre ≥ 1:20), sodium thiosulphate solut...

Each dose contains: bivalent FMD inactivated antigens of O and A strains adsorbed on to aluminium hydroxide gel. Saponin added as adjuvant chlorofom B.P as preservative 0.015mL, phosphate buffer diluent q.s

Raksha-HS+BQ vaccine contains formalin inactivated cultures of Pasteurella multocida and Clostridium chauvoei adjuvanted with aluminium hydroxide gel

Each dose contains: bivalent FMD inactivated antigens of O and Asia-1 strains adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.